Fig. 3
From: Tranexamic acid in spontaneous intracerebral hemorrhage: a meta-analysis
Pooled odds ratios for various outcomes in tranexamic acid versus placebo. A Hematoma expansion B Favorable functional outcomes (mRS 0–2 at 90 days). C Favorable functional outcomes (mRS 0–3 at 90 days). D Mortality within 90 days. E Thromboembolic events. CI, confidence interval; mRS, modified Rankin Scale; OR, odds ratio